Nucleic Acid Isolation & Purification Market to be driven by Rising demand for molecular diagnostics and personalized medicine is expected to drive market expansion in the near future at a CAGR of 8.80% during the forecast period 2024 to 2032.

Market Research Future (MRFR) has published a cooked research report on the “Global Nucleic Acid Isolation & Purification Market” that contains information from 2019 to 2032. The Nucleic Acid Isolation & Purification market is estimated to register a CAGR of 8.80% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the global Nucleic Acid Isolation & Purification market— QIAGEN, Thermo Fisher Scientific, Inc., Illumina, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Merck KGaA, Agilent Technologies, Bio-Rad Laboratories, Inc., Takara Bio Inc., Promega Corporation.

Market Highlights

The global Nucleic Acid Isolation & Purification market is accounted to register a CAGR of 8.80% during the forecast period and is estimated to reach USD 14.09 billion by 2032.

The Nucleic Acid Isolation & Purification market is experiencing robust growth due to the expanding applications of nucleic acid analysis in molecular diagnostics, drug discovery, and research. Additionally, advancements in nucleic acid extraction technologies, such as magnetic bead-based methods and automation, are enhancing workflow efficiency and accuracy, driving market adoption. With increasing demand for reliable and high-quality nucleic acid samples, the market is poised for continued expansion across pharmaceuticals, biotechnology, academic research, and clinical diagnostics sectors.

Segment Analysis

The global Nucleic Acid Isolation & Purification market has been segmented based on type, method and application.

On the basis of type, the market is segmented into DNA Isolation & Purification and RNA Isolation & Purification. The DNA isolation & purification segment was attributed to holding the largest market share in 2023 due to their widespread applications in diagnostics, research, and therapeutics.

Based on method, the global Nucleic Acid Isolation & Purification market has been segmented into Column-Based, Magnetic Beads, Reagent-Based and Others. The magnetic beads segment was expected to hold the largest market share in 2023 due to its superior efficiency, versatility, and ease of use.

Based on application, the global Nucleic Acid Isolation & Purification market has been segmented into Precision Medicine, Diagnostics, Drug Discovery & Development, Agriculture and Animal Research and Others. The diagnostics segment was expected to hold the largest market share in 2023 due to their indispensable role in disease diagnosis and monitoring.

Explore In-depth Market Details [Table of Content, List of Figures, List of Tables] of Nucleic Acid Isolation & Purification Market Research Report

Regional Analysis

The global Nucleic Acid Isolation & Purification market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Nucleic Acid Isolation & Purification market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Nucleic Acid Isolation & Purification market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Nucleic Acid Isolation & Purification market comprises the Middle East, Africa, and Latin America.

The largest market share for Nucleic Acid Isolation & Purification was maintained by the North American regional sector. This increase is attributed to the increasing demand for molecular diagnostics and genomic research applications. With the rising prevalence of genetic diseases and infectious pathogens, there is a growing need for efficient nucleic acid extraction methods for diagnostic testing and research purposes. Additionally, advancements in automation technologies and the availability of high-throughput systems are further fueling market growth by enhancing workflow efficiency and reducing turnaround times for nucleic acid purification processes.

Moreover, the Europe market has been persistently growing over the forecast period. The demand for Nucleic Acid Isolation & Purification is driven by the rising adoption of molecular diagnostics and genetic testing in clinical settings, fueled by advancements in personalized medicine and disease diagnosis. Additionally, the growing focus on research in genomics, transcriptomics, and molecular biology applications further propels the demand for efficient nucleic acid extraction and purification technologies across academic and biopharmaceutical research institutions.

Additionally, due to the increasing adoption of molecular diagnostics and genetic testing across the region, Asia Pacific is anticipated to experience the quickest growth over the forecast period. As the demand for personalized medicine and precision oncology grows, there is a rising need for efficient nucleic acid extraction methods for DNA and RNA analysis. Additionally, government initiatives aimed at enhancing healthcare infrastructure and research capabilities further contribute to the market's growth.

Furthermore, the rest of the world's Nucleic Acid Isolation & Purification market is divided into the Middle East, Africa, and Latin America. This growth is attributed to the region's rising research activities in genomics, molecular diagnostics, and biotechnology across the region. Additionally, growing investments in healthcare infrastructure and rising awareness about the importance of genetic testing and personalized medicine are driving the market growth.

Key Findings of the Study

• The global Nucleic Acid Isolation & Purification market is expected to reach USD 14.09 billion by 2032, at a CAGR of 8.80% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to the increasing adoption of molecular diagnostics and genetic testing across the region.


• Based on application, the diagnostics segment was attributed to holding the largest market in 2023, with an approximate market share of 45–60%.


• QIAGEN, Thermo Fisher Scientific, Inc., Illumina, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Merck KGaA, Agilent Technologies, Bio-Rad Laboratories, Inc., Takara Bio Inc., and Promega Corporation are the key market players.